Bionano Genomics: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Bionano Genomics (NASDAQ:BNGO) reported its Q3 earnings, missing estimated earnings by 7.45% with an EPS of $-1.01 versus an estimate of $-0.94. However, revenue was up $2.10 million from the same period last year. Last quarter, the company also missed on EPS which resulted in a 3.37% drop in the share price the next day.
November 08, 2023 | 9:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bionano Genomics missed Q3 earnings estimates, which could potentially lead to a drop in share price, similar to the 3.37% drop experienced last quarter after missing EPS estimates.
Bionano Genomics has reported a miss on its Q3 earnings estimates. This is significant as the company's share price dropped by 3.37% the day after it missed earnings estimates last quarter. Given this pattern, it's possible that the stock could experience a similar drop in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100